Avid Bioservices Inc (CDMO)
12.30
+0.05
(+0.41%)
USD |
NASDAQ |
Nov 22, 16:00
12.29
-0.01
(-0.08%)
After-Hours: 20:00
Avid Bioservices Free Cash Flow: -11.45M for July 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
July 31, 2024 | -11.45M |
April 30, 2024 | -20.85M |
January 31, 2024 | -38.50M |
October 31, 2023 | -55.94M |
July 31, 2023 | -92.96M |
April 30, 2023 | -90.52M |
January 31, 2023 | -92.40M |
October 31, 2022 | -88.99M |
July 31, 2022 | -47.76M |
April 30, 2022 | -46.95M |
January 31, 2022 | -9.279M |
October 31, 2021 | 8.002M |
July 31, 2021 | 12.94M |
April 30, 2021 | 21.32M |
January 31, 2021 | 9.865M |
October 31, 2020 | 4.737M |
July 31, 2020 | 1.759M |
April 30, 2020 | 2.015M |
January 31, 2020 | 5.149M |
October 31, 2019 | 3.941M |
July 31, 2019 | -7.963M |
April 30, 2019 | -13.10M |
January 31, 2019 | -18.03M |
October 31, 2018 | -23.12M |
July 31, 2018 | -24.81M |
Date | Value |
---|---|
April 30, 2018 | -29.78M |
January 31, 2018 | -42.78M |
October 31, 2017 | -46.22M |
July 31, 2017 | -37.21M |
April 30, 2017 | -42.80M |
January 31, 2017 | -36.85M |
October 31, 2016 | -35.21M |
July 31, 2016 | -48.34M |
April 30, 2016 | -48.47M |
January 31, 2016 | -48.53M |
October 31, 2015 | -49.45M |
July 31, 2015 | -49.40M |
April 30, 2015 | -45.07M |
January 31, 2015 | -45.14M |
October 31, 2014 | -42.07M |
July 31, 2014 | -34.85M |
April 30, 2014 | -29.01M |
January 31, 2014 | -27.17M |
October 31, 2013 | -25.48M |
July 31, 2013 | -29.64M |
April 30, 2013 | -21.78M |
January 31, 2013 | -26.08M |
October 31, 2012 | -28.06M |
July 31, 2012 | -28.09M |
April 30, 2012 | -37.43M |
Free Cash Flow Range, Past 5 Years
-92.96M
Minimum
Jul 2023
21.32M
Maximum
Apr 2021
-27.88M
Average
-11.45M
Median
Jul 2024
Free Cash Flow Benchmarks
MEI Pharma Inc | -43.43M |
Altimmune Inc | -78.12M |
Catalent Inc | 99.00M |
NovaBay Pharmaceuticals Inc | -4.812M |
Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -3.68M |
Cash from Investing (Quarterly) | -1.311M |
Cash from Financing (Quarterly) | 0.266M |
Free Cash Flow Per Share (Quarterly) | -0.0784 |
Free Cash Flow to Equity (Quarterly) | -5.265M |
Free Cash Flow to Firm (Quarterly) | -2.537M |
Free Cash Flow Yield | -1.47% |